Their research led to the prediction that, worldwide, the number of adults with type 2 diabetes will rise from 406 million in 2018 to 511 million in 2030. The study unveils that the number of adults with the disease worldwide is expected the rise by over a fifth, from 406 million in 2018 to 511 million in 2030, and India along with China and the U.S. will share over half of these high blood sugar cases.
The study, which was led by Stanford University's Sanjay Basu, found that health care providers may see a 20-percent global increase in demand for insulin in order to effectively treat type 2 diabetics. More so, China, India and the United States will represent over half of this figure.
While governments continue to encourage healthier lifestyles to prevent type 2 diabetes, the authors of the study also hope for initiatives to make life-changing insulin available and affordable. The study found that the rise in the number of people affected by the disease is likely to rise by around 20 per cent over the people affected now. Around 33 million people who require insulin presently have no acquisition to the drug. They estimated the number of people with type 2 diabetes who would need to use insulin for the next 12 years. "Despite the UN's commitment to treat non-communicable diseases and ensure universal access to drugs for diabetes, across much of the world insulin is scarce and unnecessarily hard for patients to access", said Dr Sanjay Basu, a scientist at the Stanford University and the lead author of the study, Eurekalert.org reported.
India had 69.2 million people living with diabetes in 2015 says a report of the World Health Organization
Dr. Hertzel Gerstein of McMaster University in Hamilton, Ontario, wrote in an accompanying commentary that it was important to estimate and ensure insulin supplies, but added that the forecasts should be treated cautiously as they were based on mathematical models.
"Despite the UN's commitment to treat non-communicable diseases and ensure universal access to drugs for diabetes, across much of the world insulin is scarce and unnecessarily hard for patients to access", said Basu. "The number of adults with type-2 diabetes is expected to rise over the next 12 years due to aging, urbanization, and associated changes in diet and physical activity". Unless governments commence inventiveness to make insulin accessible and economical, then its application is going to be far from appropriate. Only three manufacturers control most of the insulin supply of the world, all of which were accused of conspiring to hike prices intentionally.More news: AAA: 54 million Americans hitting the roadways this Thanksgiving holiday
More news: Chris Watts Sentenced to Life in Prison in Triple Murder Case
More news: Trump Raised Notion Of Prosecuting Clinton, Comey With Justice Officials